| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $721.3M | $640.2M | $570.6M |
| YoY Revenue Growth % | +12.7% | +12.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $303.8M | $268.8M | $236.6M |
| Operating Margin % | 42.1% | 42.0% | 41.5% |
| Net Income (GAAP) | $257.5M | $227.8M | $200.5M |
| EBITDA (Normalized) | $329.8M | $291.9M | $257.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $480.7M | $416.6M | $338.2M |
| Capital Expenditures (CapEx) | $32.5M | $28.8M | $25.7M |
| Free Cash Flow (FCF) | $448.3M | $387.8M | $312.5M |
| FCF Margin % | 62.1% | 60.6% | 54.8% |
| Return on Invested Capital (ROIC %) | 5.5% | 5.2% | 5.2% |
| Cash & Short-Term Equivalents | $1.0M | $17.5M | — |
| Total Debt (Short + Long Term) | $870.8M | $803.2M | $1.38B |
| Total Stockholders' Equity | $3.50B | $3.29B | $2.84B |